1) Amgen 
Brodalumab is a human monoclonal antibody designed for the treatment of inflammatory diseases. It is being tested for the treatment of moderate to severe psoriasis in Phase III clinical trials {as of|2013|11|lc=on}. Brodalumab was developed by Amgen, Inc. == Mechanism of action == Brodalumab binds to the interleukin-17 receptor and so prevents int...